Psychiatric Aspects of Pediatric Cancer

Pediatric Clinics of North America

Volumn 58, Issue 4, 2011, Pages 1003-1023

  Kurtz, Brian P ^a,b   Abrams, Annah N ^b,c,d  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cancer; Coping; Pediatric; Psychiatry; Psychosocial issues

Indexed keywords

ALPHA INTERFERON; BENZODIAZEPINE DERIVATIVE; CORTICOSTEROID; DEXAMETHASONE; FLUVOXAMINE; INTERFERON; METHOTREXATE; OLANZAPINE; PREDNISONE; SEROTONIN UPTAKE INHIBITOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANGER; ANTICIPATORY ANXIETY; ANTICIPATORY NAUSEA AND VOMITING; ANXIETY DISORDER; APPETITE DISORDER; ATTITUDE TO ILLNESS; AUTOIMMUNE THYROIDITIS; BEHAVIOR DISORDER; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD BEHAVIOR; CHILD CARE; CHILD PSYCHIATRY; CHILD PSYCHOLOGY; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; CHRONIC MYELOID LEUKEMIA; DECREASED APPETITE; DELIRIUM; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; EDUCATION; FATIGUE; GIANT CELL TUMOR; HUMAN; HYPERACTIVITY; INSOMNIA; IRRITABILITY; LYMPHOMA; MANIA; MELANOMA; MENTAL DETERIORATION; MENTAL DISEASE; MENTAL FUNCTION; MOOD; MOOD DISORDER; NEOPLASM; PATIENT ATTITUDE; PSYCHOSIS; RESTLESSNESS; REVIEW; SIDE EFFECT; SLEEP DISORDER; SOCIAL SUPPORT; SUPPORT GROUP; TERMINAL CARE;

EID: 80051678176     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2011.06.009     Document Type: Review

References (157)

1. Horner MJ, Ries LAG, Krapcho M, et al, editors. SEER Cancer Statistics Review, 1975-2006. Based on November 2008 SEER data submission. Bethesda (MD): National Cancer Institute. Available at: posted to the SEER web site, 2009. http://seer.cancer.gov/csr/1975_2006/.
2. National Cancer Policy Board (U.S.), Weiner S.L., Simone J.V. Childhood cancer survivorship: improving care and quality of life 2003, National Academies Press, Washington, DC.
3. Moorman J.E., Rudd R.A., Johnson C.A., et al. Centers for Disease Control and Prevention (CDC). National surveillance for asthma-United States, 1980-2004. MMWR Surveill Summ 2007, 56(SS08):1-54.
4. Writing Group for the SEARCH for Diabetes in Youth Study Group, Dabelea D., Bell R.A., et al. Incidence of diabetes in youth in the United States. JAMA 2007, 297(24):2716-2724.
5. Linabery A.M., Ross J.A. Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer 2008, 112(2):416-432.
6. O'Leary M., Krailo M., Anderson J.R., et al. Progress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology Group. Semin Oncol 2008, 35(5):484-493.
7. Pieters R., Carroll W.L. Biology and treatment of acute lymphoblastic leukemia. Pediatr Clin North Am 2008, 55(1):1-20. ix.
8. Pui C.H., Evans W.E. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006, 354(2):166-178.
9. Ris M.D., Beebe D.W. Neurodevelopmental outcomes of children with low-grade gliomas. Dev Disabil Res Rev 2008, 14(3):196-202.
10. Gottardo N.G., Gajjar A. Chemotherapy for malignant brain tumors of childhood. J Child Neurol 2008, 23(10):1149-1159.
11. Abrams A., Rauch P. Child psychiatry consultation. Rutter's textbook of child and adolescent psychiatry 2008, 1143-1155. Blackwell, Oxford (UK). 5th Edition. M. Rutter, D. Bishop, D. Pine (Eds.).
12. Massachusetts General Hospital Cancer Center Parent and family support Available at:, Accessed January 4, 2010. http://www.massgeneral.org/children/specialtiesandservices/hematology_oncology/parent_family.aspx.
13. Abrams A.N., Hazen E.P., Penson R.T. Psychosocial issues in adolescents with cancer. Cancer Treat Rev 2007, 33(7):622-630.
14. Hedström M., Ljungman G., von Essen L. Perceptions of distress among adolescents recently diagnosed with cancer. J Pediatr Hematol Oncol 2005, 27(1):15-22.
15. Evan E.E., Kaufman M., Cook A.B., et al. Sexual health and self-esteem in adolescents and young adults with cancer. Cancer 2006, 107(Suppl 7):1672-1679.
16. Weintraub M., Gross E., Kadari A., et al. Should ovarian cryopreservation be offered to girls with cancer. Pediatr Blood Cancer 2007, 48(1):4-9.
17. Kashani J., Hakami N. Depression in children and adolescents with malignancy. Can J Psychiatry 1982, 27(6):474-477.
18. Allen L., Zigler E. Psychological adjustment of seriously ill children. J Am Acad Child Psychiatry 1986, 25(5):708-712.
19. Patenaude A.F., Kupst M.J. Psychosocial functioning in pediatric cancer. J Pediatr Psychol 2005, 30(1):9-27.
20. Pai A.L., Drotar D., Zebracki K., et al. A meta-analysis of the effects of psychological interventions in pediatric oncology on outcomes of psychological distress and adjustment. J Pediatr Psychol 2006, 31(9):978-988.
21. Noll R.B., Gartstein M.A., Vannatta K., et al. Social, emotional, and behavioral functioning of children with cancer. Pediatrics 1999, 103(1):71-78.
22. Eiser C., Hill J.J., Vance Y.H. Examining the psychological consequences of surviving childhood cancer: systematic review as a research method in pediatric psychology. J Pediatr Psychol 2000, 25(6):449-460.
23. Zeltzer L.K., Recklitis C., Buchbinder D., et al. Psychological status in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2009, 27(14):2396-2404.
24. Greenberg H.S., Kazak A.E., Meadows A.T. Psychologic functioning in 8- to 16-year-old cancer survivors and their parents. J Pediatr 1989, 114(3):488-493.
25. March J., Silva S., Petrycki S., et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 2004, 292(7):807-820.
26. Kersun L.S., Elia J. Depressive symptoms and SSRI use in pediatric oncology patients. Pediatr Blood Cancer 2007, 49(7):881-887.
27. Gothelf D., Rubinstein M., Shemesh E., et al. Pilot study: fluvoxamine treatment for depression and anxiety disorders in children and adolescents with cancer. J Am Acad Child Adolesc Psychiatry 2005, 44(12):1258-1262.
28. Kersun L.S., Kazak A.E. Prescribing practices of selective serotonin reuptake inhibitors (SSRIs) among pediatric oncologists: a single institution experience. Pediatr Blood Cancer 2006, 47(3):339-342.
29. Pao M., Ballard E.D., Rosenstein D.L., et al. Psychotropic medication use in pediatric patients with cancer. Arch Pediatr Adolesc Med 2006, 160(8):818-822.
30. Patel A., Schieble T., Davidson M., et al. Distraction with a hand-held video game reduces pediatric preoperative anxiety. Paediatr Anaesth 2006, 16(10):1019-1027.
31. Liossi C., White P., Hatira P. A randomized clinical trial of a brief hypnosis intervention to control venepuncture-related pain of paediatric cancer patients. Pain 2009, 142(3):255-263.
32. Tyc V.L., Mulhern R.K., Barclay D.R., et al. Variables associated with anticipatory nausea and vomiting in pediatric cancer patients receiving ondansetron antiemetic therapy. J Pediatr Psychol 1997, 22(1):45-58.
33. Stockhorst U., Spennes-Saleh S., Körholz D., et al. Anticipatory symptoms and anticipatory immune responses in pediatric cancer patients receiving chemotherapy: features of a classically conditioned response?. Brain Behav Immun 2000, 14(3):198-218.
34. Gottschling S., Reindl T.K., Meyer S., et al. Acupuncture to alleviate chemotherapy-induced nausea and vomiting in pediatric oncology - a randomized multicenter crossover pilot trial. Klin Padiatr 2008, 220(6):365-370.
35. Friebert S. Pain management for children with cancer at the end of life: beginning steps toward a standard of care. Pediatr Blood Cancer 2009, 52(7):749-750.
36. Lewis D.A., Smith R.E. Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J Affect Disord 1983, 5(4):319-332.
37. Kershner P., Wang-Cheng R. Psychiatric side effects of steroid therapy. Psychosomatics 1989, 30(2):135-139.
38. Wolkowitz O.M., Rubinow D., Doran A.R., et al. Prednisone effects on neurochemistry and behavior. Preliminary findings. Arch Gen Psychiatry 1990, 47(10):963-968.
39. Wolkowitz O.M. Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids. Psychoneuroendocrinology 1994, 19(3):233-255.
40. Brown E.S., Suppes T. Mood symptoms during corticosteroid therapy: a review. Harv Rev Psychiatry 1998, 5(5):239-246.
41. Patten S.B., Neutel C.I. Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management. Drug Saf 2000, 22(2):111-122.
42. Warrington T.P., Bostwick J.M. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc 2006, 81(10):1361-1367.
43. Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 1972, 13(5):694-698. The Boston Collaborative Drug Surveillance Program.
44. Bender B.G., Lerner J.A., Kollasch E. Mood and memory changes in asthmatic children receiving corticosteroids. J Am Acad Child Adolesc Psychiatry 1988, 27(6):720-725.
45. Satel S.L. Mental status changes in children receiving glucocorticoids. Review of the literature. Clin Pediatr (Phila) 1990, 29(7):383-388.
46. Bender B.G., Lerner J.A., Poland J.E. Association between corticosteroids and psychologic change in hospitalized asthmatic children. Ann Allergy 1991, 66(5):414-419.
47. Hall A.S., Thorley G., Houtman P.N. The effects of corticosteroids on behavior in children with nephrotic syndrome. Pediatr Nephrol 2003, 18(12):1220-1223.
48. Stuart F.A., Segal T.Y., Keady S. Adverse psychological effects of corticosteroids in children and adolescents. Arch Dis Child 2005, 90(5):500-506.
49. Harris J.C., Carel C.A., Rosenberg L.A., et al. Intermittent high dose corticosteroid treatment in childhood cancer: behavioral and emotional consequences. J Am Acad Child Psychiatry 1986, 25(1):120-124.
50. Drigan R., Spirito A., Gelber R.D. Behavioral effects of corticosteroids in children with acute lymphoblastic leukemia. Med Pediatr Oncol 1992, 20(1):13-21.
51. Hinds P.S., Hockenberry M.J., Gattuso J.S., et al. Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia. Cancer 2007, 110(10):2321-2330.
52. Brown E.S., Chamberlain W., Dhanani N., et al. An open-label trial of olanzapine for corticosteroid-induced mood symptoms. J Affect Disord 2004, 83(2-3):277-281.
53. Pulsipher M.A. Treatment of CML in pediatric patients: should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy?. Pediatr Blood Cancer 2004, 43(5):523-533.
54. Kaban L.B., Mulliken J.B., Ezekowitz R.A., et al. Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a. Pediatrics 1999, 103(6 Pt 1):1145-1149.
55. Dickerman J.D. Interferon and giant cell tumors. Pediatrics 1999, 103(6 Pt 1):1282-1283.
56. Navid F., Furman W.L., Fleming M., et al. The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma. Cancer 2005, 103(4):780-787.
57. Renault P.F., Hoofnagle J.H., Park Y., et al. Psychiatric complications of long-term interferon alfa therapy. Arch Intern Med 1987, 147(9):1577-1580.
58. Greenberg D.B., Jonasch E., Gadd M.A., et al. Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes. Cancer 2000, 89(2):356-362.
59. Raison C.L., Demetrashvili M., Capuron L., et al. Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs 2005, 19(2):105-123.
60. Loftis J.M., Hauser P. The phenomenology and treatment of interferon-induced depression. J Affect Disord 2004, 82(2):175-190.
61. Pavol M.A., Meyers C.A., Rexer J.L., et al. Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia. Neurology 1995, 45(5):947-950.
62. Valentine A.D., Meyers C.A., Kling M.A., et al. Mood and cognitive side effects of interferon-alpha therapy. Semin Oncol 1998, 25(1 Suppl 1):39-47.
63. Hensley M.L., Peterson B., Silver R.T., et al. Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of cancer and leukemia group B 9013. J Clin Oncol 2000, 18(6):1301-1308.
64. Schaefer M., Engelbrecht M.A., Gut O., et al. Interferon alpha (IFNalpha) and psychiatric syndromes: a review. Prog Neuropsychopharmacol Biol Psychiatry 2002, 26(4):731-746.
65. Heinze S., Egberts F., Rötzer S., et al. Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial. J Immunother 2010, 33(1):106-114.
66. Kirkwood J.M., Bender C., Agarwala S., et al. Mechanisms and management of toxicities associated with high-dose interferon alfa-2b therapy. J Clin Oncol 2002, 20(17):3703-3718.
67. Hauser P., Khosla J., Aurora H., et al. A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C. Mol Psychiatry 2002, 7(9):942-947.
68. Kraus M.R., Schäfer A., Faller H., et al. Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C. Aliment Pharmacol Ther 2002, 16(6):1091-1099.
69. Dieperink E., Ho S.B., Thuras P., et al. A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C. Psychosomatics 2003, 44(2):104-112.
70. Schäfer M., Schmidt F., Amann B., et al. Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis. Neuropsychobiology 2000, 42(Suppl 1):43-45.
71. Hauser P., Soler R., Reed S., et al. Prophylactic treatment of depression induced by interferon-alpha. Psychosomatics 2000, 41(5):439-441.
72. Musselman D.L., Lawson D.H., Gumnick J.F., et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001, 344(13):961-966.
73. Moore B.D. Neurocognitive outcomes in survivors of childhood cancer. J Pediatr Psychol 2005, 30(1):51-63.
74. Mulhern R.K., White H.A., Glass J.O., et al. Attentional functioning and white matter integrity among survivors of malignant brain tumors of childhood. J Int Neuropsychol Soc 2004, 10(2):180-189.
75. Mulhern R.K., Merchant T.E., Gajjar A., et al. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 2004, 5(7):399-408.
76. Askins M.A., Moore B.D. Preventing neurocognitive late effects in childhood cancer survivors. J Child Neurol 2008, 23(10):1160-1171.
77. Nathan P.C., Patel S.K., Dilley K., et al. Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology Group. Arch Pediatr Adolesc Med 2007, 161(8):798-806.
78. Phipps S., Dunavant M., Srivastava D.K., et al. Cognitive and academic functioning in survivors of pediatric bone marrow transplantation. J Clin Oncol 2000, 18(5):1004-1011.
79. Moleski M. Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol 2000, 15(7):603-630.
80. Bhatia S. Cancer survivorship-pediatric issues. Hematology Am Soc Hematol Educ Program 2005, 507-515.
81. Butler R.W., Haser J.K. Neurocognitive effects of treatment for childhood cancer. Ment Retard Dev Disabil Res Rev 2006, 12(3):184-191.
82. Palmer S.L., Reddick W.E., Gajjar A. Understanding the cognitive impact on children who are treated for medulloblastoma. J Pediatr Psychol 2007, 32(9):1040-1049.
83. Janzen L.A., Spiegler B.J. Neurodevelopmental sequelae of pediatric acute lymphoblastic leukemia and its treatment. Dev Disabil Res Rev 2008, 14(3):185-195.
84. Mulhern R.K., Kepner J.L., Thomas P.R., et al. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group Study. J Clin Oncol 1998, 16(5):1723-1728.
85. Ris M.D., Packer R., Goldwein J., et al. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group Study. J Clin Oncol 2001, 19(15):3470-3476.
86. Little A.S., Sheean T., Manoharan R., et al. The management of completely resected childhood intracranial ependymoma: the argument for observation only. Childs Nerv Syst 2009, 25(3):281-284.
87. Steinlin M., Imfeld S., Zulauf P., et al. Neuropsychological long-term sequelae after posterior fossa tumour resection during childhood. Brain 2003, 126(Pt 9):1998-2008.
88. Kao G.D., Goldwein J.W., Schultz D.J., et al. The impact of perioperative factors on subsequent intelligence quotient deficits in children treated for medulloblastoma/posterior fossa primitive neuroectodermal tumors. Cancer 1994, 74(3):965-971.
89. Levisohn L., Cronin-Golomb A., Schmahmann J.D. Neuropsychological consequences of cerebellar tumour resection in children: cerebellar cognitive affective syndrome in a paediatric population. Brain 2000, 123(Pt 5):1041-1050.
90. Wolfe-Christensen C., Mullins L.L., Scott J.G., et al. Persistent psychosocial problems in children who develop posterior fossa syndrome after medulloblastoma resection. Pediatr Blood Cancer 2007, 49(5):723-726.
91. Buizer A.I., de Sonneville L.M., Veerman A.J. Effects of chemotherapy on neurocognitive function in children with acute lymphoblastic leukemia: a critical review of the literature. Pediatr Blood Cancer 2009, 52(4):447-454.
92. Buizer A.I., de Sonneville L.M., van den Heuvel-Eibrink M.M., et al. Behavioral and educational limitations after chemotherapy for childhood acute lymphoblastic leukemia or Wilms tumor. Cancer 2006, 106(9):2067-2075.
93. Achenbach T.M. Manual for the Child Behavior Checklist/4-18 and 1991 profiles 1991, University of Vermont Department of Psychiatry, Burlington (VT).
94. Campbell L.K., Scaduto M., Sharp W., et al. A meta-analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemia. Pediatr Blood Cancer 2007, 49(1):65-73.
95. Anderson F.S., Kunin-Batson A.S. Neurocognitive late effects of chemotherapy in children: the past 10 years of research on brain structure and function. Pediatr Blood Cancer 2009, 52(2):159-164.
96. Butler R.W., Mulhern R.K. Neurocognitive interventions for children and adolescents surviving cancer. J Pediatr Psychol 2005, 30(1):65-78.
97. Butler R.W., Sahler O.J., Askins M.A., et al. Interventions to improve neuropsychological functioning in childhood cancer survivors. Dev Disabil Res Rev 2008, 14(3):251-258.
98. Butler R.W., Copeland D.R. Attentional processes and their remediation in children treated for cancer: a literature review and the development of a therapeutic approach. J Int Neuropsychol Soc 2002, 8(1):115-124.
99. Butler R.W., Copeland D.R., Fairclough D.L., et al. A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy. J Consult Clin Psychol 2008, 76(3):367-378.
100. Poppelreuter M., Weis J., Mumm A., et al. Rehabilitation of therapy-related cognitive deficits in patients after hematopoietic stem cell transplantation. Bone Marrow Transplant 2008, 41(1):79-90.
101. Thompson S.J., Leigh L., Christensen R., et al. Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. J Clin Oncol 2001, 19(6):1802-1808.
102. Mulhern R.K., Khan R.B., Kaplan S., et al. Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. J Clin Oncol 2004, 22(23):4795-4803.
103. Conklin H.M., Khan R.B., Reddick W.E., et al. Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial. J Pediatr Psychol 2007, 32(9):1127-1139.
104. Daly B.P., Brown R.T. Scholarly literature review: management of neurocognitive late effects with stimulant medication. J Pediatr Psychol 2007, 32(9):1111-1126.
105. Barkley R.A. A review of stimulant drug research with hyperactive children. J Child Psychol Psychiatry 1977, 18(2):137-165.
106. Conklin H.M., Helton S., Ashford J., et al. Predicting methylphenidate response in long-term survivors of childhood cancer: a randomized, double-blind, placebo-controlled, crossover trial. J Pediatr Psychol 2010, 35(2):144-155.
107. Conklin H.M., Lawford J., Jasper B.W., et al. Side effects of methylphenidate in childhood cancer survivors: a randomized placebo-controlled trial. Pediatrics 2009, 124(1):226-233.
108. Children's Oncology Group Long-term follow-up guidelines for survivors of childhood, adolescent and young adult cancers, Version 3.0 October 2008, Children's Oncology Group, Arcadia (CA), Available at:, Accessed February 16, 2010. http://www.survivorshipguidelines.org.
109. Smith S.D., Rosen D., Trueworthy R.C., et al. A reliable method for evaluating drug compliance in children with cancer. Cancer 1979, 43(1):169-173.
110. Lansky S.B., Smith S.D., Cairns N.U., et al. Psychological correlates of compliance. Am J Pediatr Hematol Oncol 1983, 5(1):87-92.
111. Tebbi C.K., Cummings K.M., Zevon M.A., et al. Compliance of pediatric and adolescent cancer patients. Cancer 1986, 58(5):1179-1184.
112. Festa R.S., Tamaroff M.H., Chasalow F., et al. Therapeutic adherence to oral medication regimens by adolescents with cancer. I. Laboratory assessment. J Pediatr 1992, 120(5):807-811.
113. Tebbi C.K. Treatment compliance in childhood and adolescence. Cancer 1993, 71(Suppl 10):3441-3449.
114. de Oliveira B.M., Viana M.B., Zani C.L., et al. Clinical and laboratory evaluation of compliance in acute lymphoblastic leukaemia. Arch Dis Child 2004, 89(8):785-788.
115. Lancaster D., Lennard L., Lilleyman J.S. Profile of non-compliance in lymphoblastic leukaemia. Arch Dis Child 1997, 76(4):365-366.
116. Spinetta J.J., Masera G., Eden T., et al. Refusal, non-compliance, and abandonment of treatment in children and adolescents with cancer: a report of the SIOP working committee on phychosocial issues in pediatric oncology. Med Pediatr Oncol 2002, 38(2):114-117.
117. Die-Trill M., Stuber M.L. Psychological problems of curative cancer treatment. Psycho-oncology 1998, Oxford University Press, New York, p. 897-906. J.C. Holland (Ed.).
118. Holmes C.S., Yu Z., Frentz J. Chronic and discrete stress as predictors of children's adjustment. J Consult Clin Psychol 1999, 67(3):411-419.
119. Varni J.W., Katz E.R., Colegrove R., et al. Family functioning predictors of adjustment in children with newly diagnosed cancer: a prospective analysis. J Child Psychol Psychiatry 1996, 37(3):321-328.
120. Jobe-Shields L., Alderfer M.A., Barrera M., et al. Parental depression and family environment predict distress in children before stem cell transplantation. J Dev Behav Pediatr 2009, 30(2):140-146.
121. Dockerty J.D., Williams S.M., McGee R., et al. Impact of childhood cancer on the mental health of parents. Med Pediatr Oncol 2000, 35(5):475-483.
122. Speechley K.N., Noh S. Surviving childhood cancer, social support, and parents' psychological adjustment. J Pediatr Psychol 1992, 17(1):15-31.
123. Sloper P. Predictors of distress in parents of children with cancer: a prospective study. J Pediatr Psychol 2000, 25(2):79-91.
124. Rabineau K.M., Mabe P.A., Vega R.A. Parenting stress in pediatric oncology populations. J Pediatr Hematol Oncol 2008, 30(5):358-365.
125. Grootenhuis M.A., Last B.F. Adjustment and coping by parents of children with cancer: a review of the literature. Support Care Cancer 1997, 5(6):466-484.
126. Robinson K.E., Gerhardt C.A., Vannatta K., et al. Parent and family factors associated with child adjustment to pediatric cancer. J Pediatr Psychol 2007, 32(4):400-410.
127. Robinson K.E., Gerhardt C.A., Vannatta K., et al. Survivors of childhood cancer and comparison peers: the influence of early family factors on distress in emerging adulthood. J Fam Psychol 2009, 23(1):23-31.
128. Goldish M. SuperSibs! Available at:, Accessed January 4, 2010. http://www.supersibs.org/.
129. Sloper P. Experiences and support needs of siblings of children with cancer. Health Soc Care Community 2000, 8(5):298-306.
130. Barrera M., Fleming C.F., Khan F.S. The role of emotional social support in the psychological adjustment of siblings of children with cancer. Child Care Health Dev 2004, 30(2):103-111.
131. Streisand R., Rodrigue J.R., Houck C., et al. Brief report: parents of children undergoing bone marrow transplantation: documenting stress and piloting a psychological intervention program. J Pediatr Psychol 2000, 25(5):331-337.
132. Sahler O.J., Varni J.W., Fairclough D.L., et al. Problem-solving skills training for mothers of children with newly diagnosed cancer: a randomized trial. J Dev Behav Pediatr 2002, 23(2):77-86.
133. Sahler O.J., Fairclough D.L., Phipps S., et al. Using problem-solving skills training to reduce negative affectivity in mothers of children with newly diagnosed cancer: report of a multisite randomized trial. J Consult Clin Psychol 2005, 73(2):272-283.
134. Kazak A.E. Evidence-based interventions for survivors of childhood cancer and their families. J Pediatr Psychol 2005, 30(1):29-39.
135. Cairns N.U., Klopovich P., Hearne E., et al. School attendance of children with cancer. J Sch Health 1982, 52(3):152-155.
136. Vannatta K., Gartstein M.A., Short A., et al. A controlled study of peer relationships of children surviving brain tumors: teacher, peer, and self ratings. J Pediatr Psychol 1998, 23(5):279-287.
137. Vance Y.H., Eiser C. The school experience of the child with cancer. Child Care Health Dev 2002, 28(1):5-19.
138. Noll R.B., Bukowski W.M., Rogosch F.A., et al. Social interactions between children with cancer and their peers: teacher ratings. J Pediatr Psychol 1990, 15(1):43-56.
139. Noll R.B., Ris M.D., Davies W.H., et al. Social interactions between children with cancer or sickle cell disease and their peers: teacher ratings. J Dev Behav Pediatr 1992, 13(3):187-193.
140. Searle N.S., Askins M., Bleyer W.A. Homebound schooling is the least favorable option for continued education of adolescent cancer patients: a preliminary report. Med Pediatr Oncol 2003, 40(6):380-384.
141. Larcombe I., Charlton A. Children's return to school after treatment for cancer: study days for teachers. J Cancer Educ 1996, 11(2):102-105.
142. Pallmeyer T.P., Saylor C.F., Treiber F.A., et al. Helping school personnel understand the student with cancer: workshop evaluation. Child Psychiatry Hum Dev 1986, 16(3):205-217.
143. Katz E.R., Varni J.W., Rubenstein C.L., et al. Teacher, parent, and child evaluative ratings of a school reintegration intervention for children with newly diagnosed cancer. Child Health Care 1992, 21(2):69-75.
144. Hudson M.M., Mertens A.C., Yasui Y., et al. Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA 2003, 290(12):1583-1592.
145. Garwicz S., Möller T., Olsen J.H., et al. Association of the Nordic Cancer Registries; Nordic Society for Paediatric Haematology and Oncology. Nordic studies on late effects of treatment of cancer in childhood and adolescence. Acta Oncol 2004, 43(7):682-683.
146. Geenen M.M., Cardous-Ubbink M.C., Kremer L.C., et al. Medical assessment of adverse health outcomes in long term survivors of childhood cancer. JAMA 2007, 297(24):2705-2715.
147. Olsen J.H., Möller T., Anderson H., et al. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries. J Natl Cancer Inst 2009, 101(11):806-813.
148. Bruce M. A systematic and conceptual review of posttraumatic stress in childhood cancer survivors and their parents. Clin Psychol Rev 2006, 26(3):233-256.
149. Ross L., Johansen C., Dalton S.O., et al. Psychiatric hospitalizations among survivors of cancer in childhood or adolescence. N Engl J Med 2003, 349(7):650-657.
150. Recklitis C.J., Lockwood R.A., Rothwell M.A., et al. Suicidal ideation and attempts in adult survivors of childhood cancer. J Clin Oncol 2006, 24(24):3852-3857.
151. Zebrack B.J., Gurney J.G., Oeffinger K., et al. Psychological outcomes in long-term survivors of childhood brain cancer: a report from the childhood cancer survivor study. J Clin Oncol 2004, 22(6):999-1006.
152. Zeltzer L.K., Lu Q., Leisenring W., et al. Psychosocial outcomes and health-related quality of life in adult childhood cancer survivors: a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev 2008, 17(2):435-446.
153. Recklitis C.J., Diller L.R., Li X., et al. Suicide ideation in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2010, 28(4):655-661.
154. Beale E.A., Baile W.F., Aaron J. Silence is not golden: communicating with children dying from cancer. J Clin Oncol 2005, 23(15):3629-3631.
155. Kreicbergs U., Valdimarsdóttir U., Onelöv E., et al. Talking about death with children who have severe malignant disease. N Engl J Med 2004, 351(12):1175-1186.
156. Wolfe J., Grier H.E., Klar N., et al. Symptoms and suffering at the end of life in children with cancer. N Engl J Med 2000, 342(5):326-333.
157. Johnston D.L., Nagel K., Friedman D.L., et al. Availability and use of palliative care and end-of-life services for pediatric oncology patients. J Clin Oncol 2008, 26(28):4646-4650.